MNC Pharma Firms

Repositioning an old brand helps expand the footprint, say analysts

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

Novartis India rallied 7 per cent to Rs 709, while Abbott India gained 2 per cent to Rs 12,865 on the BSE.

MNC stocks have outperformed local peers for the first time in over a decade and have also significantly outperformed the Nifty over the last 18 months.

Indian companies importing their devices from abroad still remains only around 20 per cent of the total imports